FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315650613> ?p ?o ?g. }

• W4315650613 endingPage "1359" @default.
• W4315650613 startingPage "1359" @default.
• W4315650613 abstract "Numerous hematologic neoplasms, including acute B-lymphoblastic leukemia (B-ALL), are characterized by overexpression of anti-apoptotic BCL-2 family proteins. Despite the high clinical efficacy of the specific BCL-2 inhibitor venetoclax in acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL), dose limitation and resistance argue for the early exploration of rational combination strategies. Recent data indicated that BCL-2 inhibition in B-ALL with KMT2A rearrangements is a promising intervention option; however, combinatorial approaches have not been in focus so far. The PI3K/AKT pathway has emerged as a possible target structure due to multiple interactions with the apoptosis cascade as well as relevant dysregulation in B-ALL. Herein, we demonstrate for the first time that combined BCL-2 and PI3K/AKT inhibition has synergistic anti-proliferative effects on B-ALL cell lines. Of note, all tested combinations (venetoclax + PI3K inhibitors idelalisib or BKM-120, as well as AKT inhibitors MK-2206 or perifosine) achieved comparable anti-leukemic effects. In a detailed analysis of apoptotic processes, among the PI3K/AKT inhibitors only perifosine resulted in an increased rate of apoptotic cells. Furthermore, the combination of venetoclax and perifosine synergistically enhanced the activity of the intrinsic apoptosis pathway. Subsequent gene expression studies identified the pro-apoptotic gene BBC3 as a possible player in synergistic action. All combinatorial approaches additionally modulated extrinsic apoptosis pathway genes. The present study provides rational combination strategies involving selective BCL-2 and PI3K/AKT inhibition in B-ALL cell lines. Furthermore, we identified a potential mechanistic background of the synergistic activity of combined venetoclax and perifosine application." @default.
• W4315650613 created "2023-01-12" @default.
• W4315650613 creator A5007271388 @default.
• W4315650613 creator A5044909516 @default.
• W4315650613 creator A5070153024 @default.
• W4315650613 creator A5073556275 @default.
• W4315650613 creator A5074270747 @default.
• W4315650613 creator A5079524945 @default.
• W4315650613 creator A5087351196 @default.
• W4315650613 creator A5091378068 @default.
• W4315650613 date "2023-01-10" @default.
• W4315650613 modified "2023-09-26" @default.
• W4315650613 title "Combined BCL-2 and PI3K/AKT Pathway Inhibition in KMT2A-Rearranged Acute B-Lymphoblastic Leukemia Cells" @default.
• W4315650613 cites W1515065013 @default.
• W4315650613 cites W1974903260 @default.
• W4315650613 cites W1984621921 @default.
• W4315650613 cites W1992925022 @default.
• W4315650613 cites W2002979776 @default.
• W4315650613 cites W2009183786 @default.
• W4315650613 cites W2011360946 @default.
• W4315650613 cites W2014950302 @default.
• W4315650613 cites W2017626686 @default.
• W4315650613 cites W2020632804 @default.
• W4315650613 cites W2026743000 @default.
• W4315650613 cites W2027928327 @default.
• W4315650613 cites W2028744406 @default.
• W4315650613 cites W2030711372 @default.
• W4315650613 cites W2049517768 @default.
• W4315650613 cites W2054917860 @default.
• W4315650613 cites W2060737851 @default.
• W4315650613 cites W2066404900 @default.
• W4315650613 cites W2068912983 @default.
• W4315650613 cites W2089082314 @default.
• W4315650613 cites W2090819513 @default.
• W4315650613 cites W2097000527 @default.
• W4315650613 cites W2097767970 @default.
• W4315650613 cites W2099110265 @default.
• W4315650613 cites W2119377294 @default.
• W4315650613 cites W2136927291 @default.
• W4315650613 cites W2138504960 @default.
• W4315650613 cites W2152876030 @default.
• W4315650613 cites W2168819285 @default.
• W4315650613 cites W2192121806 @default.
• W4315650613 cites W2204493619 @default.
• W4315650613 cites W2216772862 @default.
• W4315650613 cites W2326874456 @default.
• W4315650613 cites W2474817334 @default.
• W4315650613 cites W2511409090 @default.
• W4315650613 cites W2526026167 @default.
• W4315650613 cites W2580491144 @default.
• W4315650613 cites W2589060305 @default.
• W4315650613 cites W2789223164 @default.
• W4315650613 cites W2790474168 @default.
• W4315650613 cites W2801099536 @default.
• W4315650613 cites W2884045631 @default.
• W4315650613 cites W2896783905 @default.
• W4315650613 cites W2966811667 @default.
• W4315650613 cites W2989062607 @default.
• W4315650613 cites W3012118048 @default.
• W4315650613 cites W3014584966 @default.
• W4315650613 cites W3039488989 @default.
• W4315650613 cites W3094712772 @default.
• W4315650613 cites W3131213086 @default.
• W4315650613 cites W3136623445 @default.
• W4315650613 cites W3140616468 @default.
• W4315650613 cites W4210776049 @default.
• W4315650613 cites W4283748405 @default.
• W4315650613 cites W4293102195 @default.
• W4315650613 doi "https://doi.org/10.3390/ijms24021359" @default.
• W4315650613 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36674872" @default.
• W4315650613 hasPublicationYear "2023" @default.
• W4315650613 type Work @default.
• W4315650613 citedByCount "1" @default.
• W4315650613 countsByYear W43156506132023 @default.
• W4315650613 crossrefType "journal-article" @default.
• W4315650613 hasAuthorship W4315650613A5007271388 @default.
• W4315650613 hasAuthorship W4315650613A5044909516 @default.
• W4315650613 hasAuthorship W4315650613A5070153024 @default.
• W4315650613 hasAuthorship W4315650613A5073556275 @default.
• W4315650613 hasAuthorship W4315650613A5074270747 @default.
• W4315650613 hasAuthorship W4315650613A5079524945 @default.
• W4315650613 hasAuthorship W4315650613A5087351196 @default.
• W4315650613 hasAuthorship W4315650613A5091378068 @default.
• W4315650613 hasBestOaLocation W43156506131 @default.
• W4315650613 hasConcept C179464577 @default.
• W4315650613 hasConcept C185592680 @default.
• W4315650613 hasConcept C190283241 @default.
• W4315650613 hasConcept C203014093 @default.
• W4315650613 hasConcept C2776090121 @default.
• W4315650613 hasConcept C2777938653 @default.
• W4315650613 hasConcept C2778461978 @default.
• W4315650613 hasConcept C2778729363 @default.
• W4315650613 hasConcept C2779260929 @default.
• W4315650613 hasConcept C2779675984 @default.
• W4315650613 hasConcept C2779878957 @default.
• W4315650613 hasConcept C502942594 @default.
• W4315650613 hasConcept C55493867 @default.
• W4315650613 hasConcept C75217442 @default.

• next